CH627175A5 - - Google Patents
Download PDFInfo
- Publication number
- CH627175A5 CH627175A5 CH851780A CH851780A CH627175A5 CH 627175 A5 CH627175 A5 CH 627175A5 CH 851780 A CH851780 A CH 851780A CH 851780 A CH851780 A CH 851780A CH 627175 A5 CH627175 A5 CH 627175A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- och
- piperidino
- compounds
- dimethoxy
- Prior art date
Links
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 13
- -1 pyrrolidino, piperidino, hexamethyleneimino, heptamethylene-imino, 4-methyl piperidino Chemical group 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 9
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 10
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 229910001868 water Inorganic materials 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 5
- 229960005260 amiodarone Drugs 0.000 description 5
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229960001404 quinidine Drugs 0.000 description 5
- 230000033764 rhythmic process Effects 0.000 description 5
- CJDRUOGAGYHKKD-RQBLFBSQSA-N 1pon08459r Chemical compound CN([C@H]1[C@@]2(C[C@@]3([H])[C@@H]([C@@H](O)N42)CC)[H])C2=CC=CC=C2[C@]11C[C@@]4([H])[C@H]3[C@H]1O CJDRUOGAGYHKKD-RQBLFBSQSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- CJDRUOGAGYHKKD-UHFFFAOYSA-N Iso-ajmalin Natural products CN1C2=CC=CC=C2C2(C(C34)O)C1C1CC3C(CC)C(O)N1C4C2 CJDRUOGAGYHKKD-UHFFFAOYSA-N 0.000 description 4
- 244000061121 Rauvolfia serpentina Species 0.000 description 4
- 229960004332 ajmaline Drugs 0.000 description 4
- 230000003288 anthiarrhythmic effect Effects 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 3
- BZGCEIBCKPYCNR-UHFFFAOYSA-N n-(6-hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)acetamide Chemical compound COC1=C(NC(C)=O)C(O)=C(OC)C2=C1C=CO2 BZGCEIBCKPYCNR-UHFFFAOYSA-N 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 206010047302 ventricular tachycardia Diseases 0.000 description 3
- OICCDMYPEUFYKG-UHFFFAOYSA-N 1-(2-cyclopenta[c]pyran-1-yloxyethyl)piperidine Chemical compound N1(CCCCC1)CCOC=1OC=CC2=CC=CC2=1 OICCDMYPEUFYKG-UHFFFAOYSA-N 0.000 description 2
- 125000006012 2-chloroethoxy group Chemical group 0.000 description 2
- LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 description 2
- LEHQJMAQQQVXNS-UHFFFAOYSA-N CNC(=O)NC=1OC=CC2=C(C=CC21)OCCN2CCCCC2 Chemical compound CNC(=O)NC=1OC=CC2=C(C=CC21)OCCN2CCCCC2 LEHQJMAQQQVXNS-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 description 2
- 244000166550 Strophanthus gratus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 229960003343 ouabain Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 2
- 229960000244 procainamide Drugs 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OVXSKMBWCZUKJD-UHFFFAOYSA-N 1-(1-benzofuran-5-yl)-3-methylurea Chemical compound CNC(=O)NC1=CC=C2OC=CC2=C1 OVXSKMBWCZUKJD-UHFFFAOYSA-N 0.000 description 1
- ZXNMIUJDTOMBPV-UHFFFAOYSA-N 2-chloroethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCCCl)C=C1 ZXNMIUJDTOMBPV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100026197 C-type lectin domain family 2 member D Human genes 0.000 description 1
- OUEWOGVOXZYASF-UHFFFAOYSA-N CNC(=O)NC=1OC=CC2=C(C=CC21)OC(C)N2CCCCC2 Chemical compound CNC(=O)NC=1OC=CC2=C(C=CC21)OC(C)N2CCCCC2 OUEWOGVOXZYASF-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 101000912615 Homo sapiens C-type lectin domain family 2 member D Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- HKGSWJFHYXNDJV-UHFFFAOYSA-N N-[4,7-dimethoxy-1-(2-piperidin-1-ylethoxy)cyclopenta[c]pyran-5-yl]acetamide Chemical compound C(C)(=O)NC=1C=C(C=2C=1C(=COC=2OCCN1CCCCC1)OC)OC HKGSWJFHYXNDJV-UHFFFAOYSA-N 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7621287A FR2358143A1 (fr) | 1976-07-12 | 1976-07-12 | Nouveaux aminoalcoxybenzofurannes, leur procede de preparation et leur application en therapeutique |
| FR7719658A FR2396008A2 (fr) | 1977-06-27 | 1977-06-27 | Nouveaux aminoalcoxybenzofurannes, leur procede de preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH627175A5 true CH627175A5 (sv) | 1981-12-31 |
Family
ID=26219537
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH814377A CH625234A5 (sv) | 1976-07-12 | 1977-07-01 | |
| CH851680A CH630621A5 (fr) | 1976-07-12 | 1980-11-17 | Procede de preparation de nouveaux aminoalcoxybenzofurannes. |
| CH851780A CH627175A5 (sv) | 1976-07-12 | 1980-11-17 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH814377A CH625234A5 (sv) | 1976-07-12 | 1977-07-01 | |
| CH851680A CH630621A5 (fr) | 1976-07-12 | 1980-11-17 | Procede de preparation de nouveaux aminoalcoxybenzofurannes. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4113951A (sv) |
| JP (1) | JPS6028831B2 (sv) |
| AU (1) | AU516331B2 (sv) |
| CA (1) | CA1100958A (sv) |
| CH (3) | CH625234A5 (sv) |
| DE (1) | DE2730593A1 (sv) |
| ES (3) | ES460600A1 (sv) |
| GB (1) | GB1545725A (sv) |
| GR (1) | GR61634B (sv) |
| IT (1) | IT1115363B (sv) |
| LU (1) | LU77713A1 (sv) |
| NL (1) | NL7707713A (sv) |
| SE (3) | SE441268B (sv) |
| SU (3) | SU655312A3 (sv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2447378A1 (fr) * | 1979-01-23 | 1980-08-22 | Delalande Sa | Nouveaux derives n-arylpiperazinoalcoxy-6 dimethoxy-4,7 benzofurannes, leur procede de preparation et leur application en therapeutique |
| DE3710469A1 (de) * | 1987-03-30 | 1988-10-20 | Basf Ag | Neue benzofuranderivate und diese enthaltende therapeutische mittel |
| DE3716734A1 (de) * | 1987-05-19 | 1988-12-01 | Basf Ag | Optisches aufzeichnungsmedium, das eine silicium-phthalocyaninderivat enthaltende reflektorschicht aufweist |
| DE3724756A1 (de) * | 1987-07-25 | 1989-02-09 | Basf Ag | Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel |
| DE3727736A1 (de) * | 1987-08-20 | 1989-03-02 | Basf Ag | Neue benzofuranderivate und diese enthaltende therapeutische mittel |
| US6649623B1 (en) * | 1999-02-08 | 2003-11-18 | Shionogi & Co., Ltd. | Cyclic amine derivatives and use thereof |
| AU2001279958A1 (en) * | 2000-08-17 | 2002-03-04 | Celltech R And D Limited | Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE786362A (fr) * | 1971-07-26 | 1973-01-17 | Delalande Sa | Nouveaux derives de gamma-dialkylaminoalkoxy-6 dimethoxy-4,7 benzofurannes, leur procede de preparation et leur application en therapeutique |
-
1977
- 1977-07-01 CH CH814377A patent/CH625234A5/fr not_active IP Right Cessation
- 1977-07-04 IT IT7725343A patent/IT1115363B/it active
- 1977-07-04 GR GR53872A patent/GR61634B/el unknown
- 1977-07-05 GB GB28132/77A patent/GB1545725A/en not_active Expired
- 1977-07-06 US US05/813,357 patent/US4113951A/en not_active Expired - Lifetime
- 1977-07-06 DE DE19772730593 patent/DE2730593A1/de not_active Withdrawn
- 1977-07-08 JP JP52081902A patent/JPS6028831B2/ja not_active Expired
- 1977-07-08 LU LU77713A patent/LU77713A1/xx unknown
- 1977-07-09 ES ES460600A patent/ES460600A1/es not_active Expired
- 1977-07-11 SE SE7708041A patent/SE441268B/sv not_active IP Right Cessation
- 1977-07-11 NL NL7707713A patent/NL7707713A/xx not_active Application Discontinuation
- 1977-07-12 CA CA282,550A patent/CA1100958A/fr not_active Expired
- 1977-07-12 AU AU26954/77A patent/AU516331B2/en not_active Expired
- 1977-07-12 SU SU772501204A patent/SU655312A3/ru active
-
1978
- 1978-06-14 ES ES470783A patent/ES470783A1/es not_active Expired
- 1978-06-14 ES ES470784A patent/ES470784A1/es not_active Expired
- 1978-12-25 SU SU782700463A patent/SU747425A3/ru active
- 1978-12-25 SU SU782700462A patent/SU778710A3/ru active
-
1980
- 1980-11-17 CH CH851680A patent/CH630621A5/fr not_active IP Right Cessation
- 1980-11-17 CH CH851780A patent/CH627175A5/fr not_active IP Right Cessation
-
1983
- 1983-01-28 SE SE8300445A patent/SE8300445L/sv not_active Application Discontinuation
- 1983-01-28 SE SE8300446A patent/SE8300446L/sv not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6028831B2 (ja) | 1985-07-06 |
| GR61634B (en) | 1978-12-04 |
| ES460600A1 (es) | 1978-12-01 |
| SU655312A3 (ru) | 1979-03-30 |
| CA1100958A (fr) | 1981-05-12 |
| AU516331B2 (en) | 1981-05-28 |
| ES470783A1 (es) | 1979-09-01 |
| SU778710A3 (ru) | 1980-11-07 |
| GB1545725A (en) | 1979-05-16 |
| SE8300446D0 (sv) | 1983-01-28 |
| SE8300445D0 (sv) | 1983-01-28 |
| SE8300445L (sv) | 1983-01-28 |
| DE2730593A1 (de) | 1978-01-19 |
| CH625234A5 (sv) | 1981-09-15 |
| NL7707713A (nl) | 1978-01-16 |
| SE441268B (sv) | 1985-09-23 |
| AU2695477A (en) | 1979-01-18 |
| SE8300446L (sv) | 1983-01-28 |
| IT1115363B (it) | 1986-02-03 |
| US4113951A (en) | 1978-09-12 |
| ES470784A1 (es) | 1979-01-16 |
| SU747425A3 (ru) | 1980-07-23 |
| LU77713A1 (sv) | 1978-01-31 |
| CH630621A5 (fr) | 1982-06-30 |
| SE7708041L (sv) | 1978-01-13 |
| JPS5412365A (en) | 1979-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH653021A5 (fr) | Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant. | |
| EP0373998B1 (fr) | Ethers d'oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| FR2479825A1 (fr) | Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments | |
| CH650780A5 (fr) | N-aryl oxazolidinones-2, leur procede de preparation et composition pharmaceutique les contenant. | |
| EP0157267B1 (de) | Substituierte Benzopyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| EP0435749A1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
| AU648090B2 (en) | Carbostyril derivatives | |
| FR2639044A1 (fr) | Derives de la butynylamine | |
| CH627175A5 (sv) | ||
| FR2460294A1 (fr) | Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant | |
| EP0301936A1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique | |
| EP0101380A2 (fr) | Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant | |
| EP1687312B1 (fr) | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques | |
| CH662354A5 (fr) | Derives de l'hydantoine, procede pour leur preparation et medicament contenant ces derives. | |
| BG63917B1 (bg) | 1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им | |
| EP0035619B1 (fr) | Dérivés d'amino-3 (1H,3H) quinazolinedione-2,4 | |
| EP0106860B1 (fr) | Nouvelles carboxamidoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant | |
| EP0082058A1 (fr) | Ethers d'oximes de pyridyl-1 pentanone-3, leur procédé de préparation et leur utilisation comme médicament | |
| EP0284552A1 (de) | 4-Benzyl-piperazinyl-Hydrazone | |
| FR2552762A1 (fr) | Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique | |
| JPS6038383B2 (ja) | 新規１−〔３−（３，４，５−トリメトキシフェノキシ）−２−ヒドロキシ−プロピル〕−４−アリ−ル−ピペラジン誘導体及びその製造法 | |
| US3701786A (en) | Dibenzofuranyl-aminoalcohols | |
| EP0103503A2 (fr) | Amides N-substitués, leurs sels, procédé pour leur préparation et compositions pharmaceutiques en contenant | |
| BE819057A (fr) | Nouveaux derives arylamino pyrimidiniques | |
| US3983169A (en) | Phenoxypropylamine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |